Inovio's (INO) DNA Technology Platform Further Validated with Latest Qtr. Results - Stifel
Tweet Send to a Friend
Stifel affirms its Buy rating and $19 price target on Inovio (Nasdaq: INO) following the company's Q3 report and update ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
